MethodMethod
Method

Method

Develops an AI-driven surgical navigation platform using 3D ultrasound for enhanced cancer treatment.

2021Inactive
Rate

About

Method AI is developing a novel surgical navigation platform that leverages continuous 3D ultrasound imaging and AI-driven algorithms. This technology creates subsurface maps and surgical plans to guide physicians during procedures, with the goal of improving cancer-free survival rates and reducing healthcare costs.

Technology stack

detected 2026-06-16
Est. monthly stack spend~$70/mo
Emailnone
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Method do?

Method AI is developing a novel surgical navigation platform that leverages continuous 3D ultrasound imaging and AI-driven algorithms. This technology creates subsurface maps and surgical plans to guide physicians during procedures, with the goal of improving cancer-free survival rates and reducing healthcare costs.

How much funding has Method raised?

Method has raised a total of $20M in funding. The most recent round on record is Series A.

Where is Method headquartered?

Method is headquartered in San Francisco, United States.

When was Method founded?

Method was founded in 2021.

What industry does Method operate in?

Method operates in MedTech, HealthTech, Surgical Robotics, AI-Driven Drug Discovery, Computer Vision, 3D Imaging.

What is Method's current status?

Method's current operating status is: Inactive.